Economy/Home · Economy

[Breaking] HLB Therapeutics Changes Payment Date for 17th and 18th Convertible Bond Early Redemption and Paid-In Capital Increase to August 31

HLB Therapeutics announced in a regulatory filing that it has changed the schedule for the early redemption and pre-maturity acquisition of its 17th and 18th series convertible bonds (CB) as well as its third-party allotment paid-in capital increase. The key payment and deposit dates have been moved

Oseong Kwon
Staff Reporter
8 min read
[Breaking] HLB Therapeutics Changes Payment Date for 17th and 18th Convertible Bond Early Redemption and Paid-In Capital Increase to August 31
CBC News

HLB Therapeutics announced in a regulatory filing that it has changed the schedule for the early redemption and pre-maturity acquisition of its 17th and 18th series convertible bonds (CB) as well as its third-party allotment paid-in capital increase. The key payment and deposit dates have been moved from August 20 to August 31.

■ Convertible Bond Early Redemption Schedule and Yield Changed

HLB Therapeutics changed the second early redemption payment date of the 17th series convertible bond from August 20, 2026, to August 31. The early redemption yield was also changed from 101.7716% to 101.8046%. The 17th series convertible bond has a total face value of 6 billion won, and its subscriber is HLB, the largest shareholder.

The first early redemption payment date of the 18th series convertible bond was likewise changed from August 20 to August 31. The early redemption yield was adjusted from 101.4947% to 101.5273%. The 18th series convertible bond has a total face value of 5 billion won, with HLB as the subscriber. The company stated that the reason for changing the issuance terms of both bonds was an agreement with the bondholders.

■ Paid-In Capital Increase Payment and Listing Schedule Adjusted

The schedule for the third-party allotment paid-in capital increase was also changed. In accordance with an agreement with the third-party allottees, the payment date was changed from August 20 to August 31, and the scheduled listing date of the new shares was changed from September 8 to September 16.

The paid-in capital increase will issue 6,103,185 common shares at 1,832 won per share. The disclosed amount of other funds to be raised is 11,181,034,920 won, and the third-party allottee is HLB, the largest shareholder. The new shares will be placed under lockup for one year from the listing date.

According to the filing, the purpose of the capital increase is to repay debt through debt-to-equity conversion and improve the financial structure. The claims held by the third-party allottee against the company—6 billion won from the 17th series convertible bond and 5 billion won from the 18th series convertible bond—will be offset against the obligation to pay in the capital.

■ Pre-Maturity Bond Acquisition Amount Corrected… Full Cancellation

The initial capital increase filing stated the offset amounts as 6,100,629,900 won for the 17th series and 5,074,736,000 won for the 18th series. These amounts were subsequently changed in a corrected filing regarding the pre-maturity bond acquisition.

For the 18th series convertible bond, in accordance with an agreement with the bondholder, the acquisition amount was changed from 5,074,736,000 won to 5,076,771,373 won, with the payment scheduled for August 31. The acquisition covers the entire face value of 5 billion won, leaving a remaining face value of zero after acquisition. The reason for the pre-maturity acquisition is the bondholder's exercise of the early redemption right, and the company plans to cancel the bonds registered with the Korea Securities Depository after acquisition.

For the 17th series convertible bond, the acquisition amount was changed from 6,100,629,900 won to 6,109,069,890 won, with the acquisition date adjusted to August 31. The bonds to be acquired have a total face value of 6 billion won, leaving a total face value of zero after acquisition. The company stated that the reason for the pre-maturity acquisition and its future handling method are debt offset through debt-to-equity conversion and cancellation of the bonds. The source of the acquisition funds is the offset of the third-party allotment paid-in capital increase proceeds, and the acquisition method is an over-the-counter purchase.

■ 17th Series CB Conversion Price Stated as 6,090 Won

The stated conversion price per share of the 17th series convertible bond is 6,090 won. The company stated that this conversion price reflects adjustments due to a decline in market price as well as bonus share issuances on December 19, 2024, January 13, 2025, and March 13, 2026.

Oseong Kwon
Staff Reporter

CBC Globe publishes verified stories with editorial review, source checks, and tenant-specific publication standards.